New Prenatal Opportunity Assessment

Project Overview

A multinational pharmaceutical and diagnostics company was interested in learning more about the U.S. market opportunity for their novel noninvasive prenatal test in development

DeciBio Approach

Secondary Research

Aggregated secondary research on regulations and guidelines concerning invasive and noninvasive prenatal testing in the U.S.
Assessed the coverage landscape for invasive and prenatal testing
Analyzed clinical trials and publications to estimate trial size and rigor for market acceptance of a novel test

‍Primary Research

Conducted 25 in-depth stakeholder interviews with lab directors and OB/GYN doctors directly involved with ordering or running invasive and noninvasive prenatal tests
Interviewees included doctors in community based and academic settings as well as lab directors from molecular and cytogenetic labs

Quantitative Analysis

Estimated the current levels of invasive and noninvasive prenatal testing to produce estimates of the potential market opportunity in the U.S.

At a glance

Stakeholder Interviews

Prenatal Testing Markets Sized

Go-To-Market Strategies Proposed

Outcomes

DeciBio shared research findings with the client, key takeaways included:

Outlined customer requirements and key considerations and recommendations to help inform the client’s product development
Proposed possible strategies to enter the U.S. market to better inform the client’s product strategy

Timeline

3.5 weeks

Geographic Scope

U.S.

Industry

Clinical Diagnostics

capabilities

Voice-Of-Customer Research

Go-to-Market Strategy

Addressable Market Sizing

Cell and Gene Therapy Services Landscape Assessment

Cell and Gene Therapy Service Market Opportunity Assessment

Synthetic Oligonucleotides Market Sizing